MedTrace Logo

Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders

NCT00438685 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-06-14

No results posted yet for this study

Summary

Adolescent substance abuse results in significant negative outcomes and extraordinary costs for youths, their families, communities, and society. Moreover, rates of psychiatric comorbidity among substance abusing youth range from 25% up to 82%, and youths with a dual diagnosis have worse outcomes and are more than twice as costly to treat than their counterparts with no comorbidity. This project was a pilot test of a new treatment, OPTION-A, which was adapted from Multisystemic Therapist (MST) and other evidence-based interventions to specifically treat youth presenting for outpatient treatment of comorbid substance use and internalizing disorders. The project was a randomized controlled pilot trial comparing the experimental treatment to usual services in the community.

Conditions

  • Substance-Related Disorders
  • Depressive Disorder
  • Anxiety Disorder

Interventions

BEHAVIORAL

Outpatient MST/OPTION-A

BEHAVIORAL

Usual Services

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Medical University of South Carolina

    lead OTHER

Principal Investigators

  • Ashli J Sheidow, PhD · Medical University of South Carolina, Department of Psychiatry & Behavioral Sciences, Family Services Research Center

  • Scott W Henggeler, PhD · Medical University of South Carolina, Department of Psychiatry & Behavioral Sciences, Family Services Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2007-08-31
Completion
2010-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00438685 on ClinicalTrials.gov